# Hour 06 PSL Scores: 06:00-06:59

Released on 23 March 2026 | CEO Kevin Kawchak | ChemicalQDevice

## PSL Scores at End of Hour 06

| Robot Type | Dim A (Omniscient) | Dim B (Omnipresent) | Dim C (Omnipotent) | PSL | Delta | Band |
|-----------|-------------------|--------------------|--------------------|-----|-------|------|
| Surgical Robots | 7.2 | 5.8 | 7.5 | 6.8 | - | Advanced |
| Cobots | 7.0 | 6.5 | 6.2 | 6.6 | - | Advanced |
| RT Positioning | 7.5 | 6.0 | 6.8 | 6.8 | - | Advanced |
| Needle-Placement | 6.8 | 5.5 | 6.5 | 6.3 | - | Advanced |
| Social Companion | 5.5 | 7.2 | 4.0 | 5.6 | - | Intermediate |
| Humanoids | 5.8 | 6.0 | 5.3 | 5.7 | +0.1 (Dim C) | Intermediate |
| RT Motion-Tracking | 7.8 | 6.2 | 7.0 | 7.0 | - | Advanced |
| Imaging Assistant | 7.0 | 6.8 | 5.8 | 6.5 | - | Advanced |
| Steerable Needle | 7.3 | 5.2 | 7.0 | 6.5 | +0.1 (Dim A) | Advanced |
| Rehab Exoskeletons | 5.5 | 5.8 | 5.5 | 5.6 | - | Intermediate |

## Cumulative Site PSL: 64.0 (Advanced Site)

Previous cumulative: 63.8. This hour: +0.2 (Humanoid Dim C +0.1,
Steerable Needle Dim A +0.1).

## Scoring Changes This Hour

### Humanoid Robots: Dim C (Omnipotent) 5.2 -> 5.3 (+0.1)

Justification: HUMAN-01 successfully completed a pediatric physical therapy
session for PAT-ODMND-0020 (11M, osteosarcoma). The session demonstrated
the humanoid's capability to conduct a full therapeutic protocol including
grip strength assessment (8.2 kg, improved from 7.9 kg prior session),
balance evaluation (6.5/10), and coordination drills (14/20 ball catch, 85%
finger tracking). The session showed improvement in patient metrics compared
to prior baseline, validating the humanoid's therapeutic omnipotence in a
pediatric oncology rehabilitation context. The successful handoff from
HUMAN-01 to REHAB-02 also demonstrated cross-robot procedural coordination.

Regulatory basis: ICH E6(R3) Section 4.2.1 requires documentation of
procedure outcomes. The measurable improvement in grip strength (+0.3 kg
bilateral) provides objective evidence of therapeutic benefit supporting
the omnipotence score increase.

### Steerable Needle Robots: Dim A (Omniscient) 7.2 -> 7.3 (+0.1)

Justification: STEER-01 demonstrated enhanced pre-ablation data integration
during the HCC ablation procedure for PAT-ODMND-0022. The AI-calculated
needle path incorporated planning CT data, prior imaging history, liver
segmentation model, and real-time CT fluoroscopy into a unified trajectory
plan targeting a 14 mm segment VI lesion. Additionally, during the vasovagal
near-miss event, STEER-01's auto-lock system demonstrated real-time
awareness of needle position (maintained within 0.1 mm during 2-minute
pause), reflecting strong omniscient capability in a safety-critical
context. The auto-lock engaged in 15 ms, confirming the system's
continuous positional awareness.

Regulatory basis: 21 CFR Part 312 Section 312.62 requires thorough
investigator recordkeeping. STEER-01's comprehensive data integration
for ablation planning and the complete documentation of the near-miss
event including needle telemetry during auto-lock directly support
the omniscient dimension score increase.

## Dimension Analysis

### Dimension A (Omniscient) - ICH E6(R3) Alignment

- Steerable Needle improvement (+0.1) reflects enhanced multi-modal data
  fusion: planning CT, real-time fluoroscopy, AI trajectory model, and
  continuous 120 Hz positional awareness during auto-lock event.
- RT Motion-Tracking maintained 7.8 with TRACK-03 demonstrating 120 Hz
  marker tracking and 92.5% gating efficiency for PAT-ODMND-0019.
  IND drug administration (atezolizumab) integrated into digital twin
  per ICH E6(R3) Section 2.9.1 audit trail requirements.
- RT Positioning maintained 7.5 with RTPOS-02 achieving 98.2% CBCT
  auto-registration confidence for PAT-ODMND-0018 brain RT.
- Cobot maintained 7.0 with COBOT-03 AI tissue quality assessment
  grading all 4 cores as Grade A within 8 ms inference latency.

### Dimension B (Omnipresent) - 21 CFR Part 50 Alignment

- No changes this hour. Peak utilization reached approximately 20% with
  6 robots active simultaneously at peak, but no single robot type
  approached capacity limits that would trigger an omnipresence
  reassessment.
- Social Companion maintained 7.2 with COMPN-03 demonstrating seamless
  transition from overnight passive monitoring to active morning
  interaction mode for PAT-ODMND-0005.
- Pediatric protections per 21 CFR Part 50 Subpart D maintained for
  both PAT-ODMND-0005 (companion) and PAT-ODMND-0020 (humanoid/rehab).

### Dimension C (Omnipotent) - 21 CFR Part 312 Alignment

- Humanoid improvement (+0.1) reflects successful pediatric therapy
  session with measurable patient improvement metrics. HUMAN-01
  demonstrated grip assessment, balance evaluation, and coordination
  training in a single integrated session, expanding demonstrated
  procedural range.
- Steerable Needle maintained 7.0 in Dim C. Ablation procedure in
  progress at hour end; Dim C reassessment pending completion in
  Hour 07.
- Cobot maintained 6.2 with COBOT-03 completing a Grade A biopsy
  with 2 repositionings, consistent with established capability.

## PSL Trend Summary (Hours 00-06)

| Hour | Cumulative Site PSL | Notable Changes |
|------|--------------------|-|
| 00 | 63.4 | Baseline established |
| 01 | 63.4 | No changes (low volume) |
| 02 | 63.4 | No changes (low volume) |
| 03 | 63.5 | Minor adjustment |
| 04 | 63.6 | Minor adjustment |
| 05 | 63.8 | Pre-ramp adjustments |
| 06 | 64.0 | Humanoid +0.1 Dim C, Steerable Needle +0.1 Dim A |

## USL Comparison Note

The USL framework (Kawchak, 2026; DOI: 10.5281/zenodo.18778220) evaluates
robot technical interoperability. The STEER-01 auto-lock function during
the vasovagal event represents a safety engineering feature evaluated under
USL criteria for real-time system responsiveness. The 15 ms auto-lock
activation time and 0.1 mm positional maintenance during the 2-minute
pause are consistent with USL Intermediate band specifications for
steerable needle platforms.

HUMAN-01's pediatric therapy session utilized mirror-mode demonstration
capability, a feature assessed under USL for human-robot interaction
fidelity. The 97% match to prescribed exercise protocol reflects the
technical interoperability evaluated by USL translating into clinical
omnipotence measured by PSL.

The single-patient cancer journey framework (Kawchak, 2026;
DOI: 10.5281/zenodo.19119939) established PSL scoring methodology for
individual patient interactions. Hour 06 extends this to concurrent
multi-patient scoring, where improvements in one robot type's PSL are
driven by accumulated evidence across multiple patient interactions
rather than a single patient journey.

## Near-Miss Event PSL Impact Assessment

The vasovagal near-miss for PAT-ODMND-0022 was evaluated for PSL impact:

- Dim A (Omniscient): Positive impact. STEER-01 demonstrated continuous
  positional awareness during the event, contributing to the +0.1 increase.
- Dim B (Omnipresent): No impact. Event was localized to a single robot
  instance.
- Dim C (Omnipotent): No impact. The event did not result in procedural
  failure. Ablation continued successfully after 2-minute pause.

The event validates the PSL framework's ability to capture safety-relevant
robot performance in near-miss scenarios, consistent with ICH E6(R3)
Section 3.3.7 documentation requirements.
